Athira Pharma Inc.

NAS: ATHA

GO
/marketstate/country/us

Market open

/zigman2/quotes/221121520/composite

$

3.97

Change

+0.01 +0.25%

Volume

Volume 12,719

Aug 17, 2022, 9:44 a.m.

Real time quotes

/zigman2/quotes/221121520/composite

Previous close

$ 3.96

$ 3.97

Change

+0.01 +0.25%

Day low

Day high

$3.92

$3.99

Open
Open: 3.93

52 week low

52 week high

$2.53

$16.65

Open

Market cap

$149.04M

Average volume

1.19M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.06

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/atha

MarketWatch News on ATHA

  1. Rapid Micro, Athira Pharma See Activist Investor Action

    9:31 p.m. July 8, 2022

    - Barron's Online

  2. Athira Pharma started at buy with $6 stock price target at Mizuho

    7:05 a.m. July 7, 2022

    - Tomi Kilgore

  3. Athira Pharma Falls 40% Amid Questions About CEO's PhD Research

    9:42 a.m. June 18, 2021

    - Barron's Online

  4. What to Know About the FDA's Approval of Biogen's Alzheimer's Drug

    10:47 a.m. June 8, 2021

    - Barron's Online

  5. Athira Pharma started at buy with $36 stock price target at Stifel Nicolaus

    7:11 a.m. Oct. 13, 2020

    - Tomi Kilgore

  6. Athira Pharma's stock pulls back after the open, trades briefly below IPO price

    12:06 p.m. Sept. 18, 2020

    - Tomi Kilgore

  7. Athira Pharma stock's first trade was at $19.95, or 17.4% above the IPO price

    12:02 p.m. Sept. 18, 2020

    - Tomi Kilgore

  8. Athira Pharma's stock indicated to open around $22.00, or 29% above $17 IPO price

    10:45 a.m. Sept. 18, 2020

    - Tomi Kilgore

  9. Athira Pharma prices upsized IPO at $17, high end of price range

    6:27 a.m. Sept. 18, 2020

    - Ciara Linnane

  10. Athira Pharma to raise up to $170 million in IPO

    6:20 a.m. Sept. 14, 2020

    - Tomi Kilgore

  11. Athira Pharma sets IPO terms, to raise up to $170 mln

    6:11 a.m. Sept. 14, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/atha

Other News on ATHA

  1. 10-Q: ATHIRA PHARMA, INC.

    5:31 p.m. Aug. 15, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Athira Pharma downgraded at JMP after Alzheimer’s setback

    2:34 p.m. June 23, 2022

    - Seeking Alpha

  3. Athira And Alzheimer's

    6:56 a.m. June 23, 2022

    - Seeking Alpha

  4. MFGP, OMER and ZYXI among mid-day movers

    12:54 p.m. June 22, 2022

    - Seeking Alpha

  5. Why Athira Pharma Stock Imploded Today

    11:31 a.m. June 22, 2022

    - Motley Fool

  6. Anavex's Blarcamesine: Why It May Treat Alzheimer's Disease

    7:28 p.m. June 2, 2022

    - Seeking Alpha

  7. Pathways Impacting Alzheimer's Disease Drug Development

    5:43 a.m. April 19, 2022

    - Seeking Alpha

  8. Athira Pharma (ATHA) Investor Presentation - Slideshow

    2:48 p.m. April 14, 2022

    - Seeking Alpha

  9. 10-K: ATHIRA PHARMA, INC.

    4:15 p.m. March 28, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  10. Loading more headlines...
/news/pressrelease/company/us/atha

Press Releases on ATHA

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.